Fukushima Medical University · Department of Thoracic Surgery · 教授

Research keywordsがん免疫代謝・腫瘍免疫・がん免疫療法・メチオニン代謝・腸内細菌叢

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Nucleolar casein kinase 2 alpha as a prognostic factor in patients with surgically resected early‑stage lung adenocarcinoma.2025 · Muto S, Homma MK, Kiko Y, Ozaki Y, Watanabe M, Okabe N, Hamada K, Hashimoto Y, Suzuki H
• Tumor β-Catenin Expression Associated With Poor Prognosis to Anti-PD-1 Antibody Monotherapy in Non-small Cell Lung Cancer.2025 · Muto S, Ozaki Y, Yamaguchi H, Watanabe M, Okabe N, Matsumura Y, Hamada K, Suzuki H
• Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study.2025 · Tsurui T, Hamada K, Mura E, Suzuki R, Iriguchi N, Ishiguro T, Hirasawa Y, Ohkuma R, Shimokawa M, Ariizumi H, Kubota Y, Horiike A, Wada S, Yoshimura K, Tsuji M, Kiuchi Y, Tsunoda T
• Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody.2024 · Murayama M, Hosonuma M, Kuramasu A, Kobayashi S, Sasaki A, Baba Y, Narikawa Y, Toyoda H, Isobe J, Funayama E, Tajima K, Sasaki A, Maruyama Y, Yamazaki Y, Shida M, Hamada K, Hirasawa Y, Tsurui T, Ariizumi H, Ishiguro T, Suzuki R, Ohkuma R, Kubota Y, Horiike A, Sambe T, Tsuji M, Wada S, Kobayashi S, Shimane T, Tsunoda T, Kobayashi H, Kiuchi Y, Yoshimura K.

• がん免疫療法耐性固形がんに対する高食物繊維摂取下での免疫チェックポイント阻害剤の有効性の検証2024 · 2024年12月
• MTAP遺伝子欠失をもつ大腸癌の癌微小環境における免疫細胞の活性化機序の解明2022 · 2022年4月
• 肺内細菌叢に着目した腫瘍微小環境の形成メカニズム解析
• 空間プロテオームで解明するメチオニン制限による肺癌細胞死、統合ストレス応答の関係

• Official profile